California sues organizations for touting abortion pill reversal
Send a link to a friend
[September 22, 2023]
By Brendan Pierson
(Reuters) - California on Thursday sued two anti-abortion organizations
for telling patients that they can help reverse the effects of the
abortion pill mifepristone, a potentially dangerous claim not supported
by evidence.
In a complaint filed in Alameda County Superior Court, California
Attorney General Rob Bonta, a Democrat, accused Heartbeat International
(HBI) and RealOptions Obria of violating a state law against fraudulent
business practices.
"Those who are struggling with the complex decision to get an abortion
deserve support and trustworthy guidance - not lies and misinformation,"
Bonta said in a statement.
His lawsuit seeks a court order blocking the defendants from advertising
abortion pill reversal, though it does not seek to stop the practice
itself.
HBI said in a statement that it had not yet been served with the
lawsuit. It said women who regret taking mifepristone "deserve the right
to try and save their pregnancies."
RealOptions did not immediately respond to a request for comment.
RealOptions operates five crisis pregnancy centers in California, and
provides abortion pill reversal, according to the complaint. Such
centers offer help to pregnant women with the goal of preventing them
from having abortions.
HBI is an international anti-abortion group affiliated with more than
2,000 crisis pregnancy centers around the country. Through its website,
it offers to connect women to providers who will perform abortion pill
reversal.
[to top of second column]
|
A container holding boxes of Mifepristone, the first medication in a
medical abortion, are prepared for patients at Alamo Women's Clinic
in Carbondale, Illinois, U.S., April 20, 2023. REUTERS/Evelyn
Hockstein/File Photo
Mifepristone is taken as the first
step in medication abortion, followed by a second drug, misoprostol.
Proponents of medication abortion reversal say mifepristone's
effects can be blocked by a high dose of the hormone progesterone.
The only clinical trial of the process was halted early after three
of 12 patients experienced severe bleeding requiring them to go to
the hospital.
Colorado earlier this year banned the treatment. Kansas passed a law
requiring healthcare providers to tell patients that medication
abortion can be reversed, which Planned Parenthood is challenging.
A Texas judge in April suspended federal approval for mifepristone
in response to a lawsuit by anti-abortion activists. His order is on
hold while President Joe Biden's administration appeals it to the
U.S. Supreme Court.
(Reporting By Brendan Pierson in New York, Editing by Alexia
Garamfalvi and Bill Berkrot)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|